Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-009651
Filing Date
2025-04-02
Accepted
2025-04-02 16:31:50
Documents
2
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form3-04022025_080447.html 3  
1 form3-04022025_080447.xml 3 2364
2 ex24-04022025_080451.htm EX-24 6988
  Complete submission text file 0001415889-25-009651.txt   10821
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AXOVANT SCIENCES, INC. 11 TIMES SQUARE, 33RD FLOOR NEW YORK NY 10036
Business Address
Corcoran Gavin (Reporting) CIK: 0001745995 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38529 | Film No.: 25805251